Endothelin Receptor Function and Acute Stress (End-Stress)

Trial Profile

Endothelin Receptor Function and Acute Stress (End-Stress)

Phase of Trial: Phase III

Latest Information Update: 14 Nov 2017

At a glance

  • Drugs Bosentan (Primary)
  • Indications Acute traumatic stress disorders
  • Focus Therapeutic Use
  • Acronyms End-Stress
  • Most Recent Events

    • 17 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 10 Dec 2014 Planned initiation date changed from 1 May 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
    • 20 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top